Biogen Idec’s Tecfidera (dimethyl fumarate) has been approved by the FDA for the treatment of people with relapsing forms of multiple sclerosis (MS).  The wholesale acquisition price for Tecfidera is reported to be $54,900,  about 9% less than the first MS …

Tecfidera for MS is $55,000 per year. Why? Read More »